The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict Here's a roundup of top developments ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

Digital health company Akili is on the brink of its first major expansion beyond the US, partnering with Shionogi to file a localised version of its attention deficit hyperactivity disorder (ADHD ...

Here’s how it works. That final phone may steal much of the attention, but it’s the iPhone 17 Pro Max that will probably have the most impressive specs. And while we’re not expecting it to ...

The Pixel 7 and Pixel 7 Pro were highly anticipated releases in late 2022. Despite their iterative natures, it’s great to see Google pick a direction and stick with it for at least two years.

The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce that APRETUDE (cabotegravir tablets and ...

Defining and categorizing long COVID has confounded clinicians and researchers since the condition was first identified in the throes of the pandemic, and the challenge continues today. In June ...

Shionogi & Co., Ltd. 2024 Q3 - Results - Earnings Call Presentation Fri, Jan. 31 Earnings Call Insights Shionogi targets JPY550B revenue through QOL focus and global expansion ...